Molecular mechanisms underlying variations in lung function: A systems genetics analysis

The Lancet Respiratory Medicine

Volumn 3, Issue 10, 2015, Pages 782-795

  Obeidat, Ma'en ^a   Hao, Ke ^b   Bossé, Yohan ^c,d   Nickle, David C ^e   Nie, Yunlong ^a   Postma, Dirkje S ^f   Laviolette, Michel ^d   Sandford, Andrew J ^a   Daley, Denise D ^a   Hogg, James C ^a,g   Elliott, W Mark ^a,g   Fishbane, Nick ^a   Timens, Wim ^f   Hysi, Pirro G ^h   Kaprio, Jaakko ^i,j   Wilson, James F ^k,l   Hui, Jennie ^m,n,o   Rawal, Rajesh ^p   Schulz, Holger ^p,q   Stubbe, Beate ^r   Hayward, Caroline ^l   Polasek, Ozren ^k,s   Järvelin, Marjo Riitta ^t,v   Zhao, Jing Hua ^w   Jarvis, Deborah ^t,u   Kähönen, Mika ^x   Franceschini, Nora ^y   North, Kari E ^y,z   Loth, Daan W ^aa   Brusselle, Guy G ^aa,ab   Smith, Albert Vernon ^ac,ad   Gudnason, Vilmundur ^ac,ad   Bartz, Traci M ^ae   Wilk, Jemma B ^ag   O'Connor, George T ^ah,ai   Cassano, Patricia A ^aj,ak   Tang, Wenbo ^aj,al   Wain, Louise V ^am,an   Artigas, María Soler ^am,an   Gharib, Sina A ^ae,af   Strachan, David P ^ao   Sin, Don D ^a   Tobin, Martin D ^am,an   London, Stephanie J ^ap   Hall, Ian P ^aq   Paré, Peter D ^a   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UNIVERSITY OF EDINBURGH   (United Kingdom)

^m Busselton Population Medical Research Foundation   (Australia)

ⁿ PATHWEST LABORATORY MEDICINE   (Australia)

^o UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^p INSTITUTE OF EPIDEMIOLOGY   (Germany)

^q German Center for Lung Research   (Germany)

^r UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^s UNIVERSITY OF SPLIT   (Croatia)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^v OULU UNIVERSITY HOSPITAL   (Finland)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^x TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^y IL   (United States)

^z UNIVERSITY OF NORTH CAROLINA   (United States)

^aa ERASMUS MEDICAL CENTER   (Netherlands)

^ab GHENT UNIVERSITY HOSPITAL   (Belgium)

^ac ICELANDIC HEART ASSOCIATION   (Iceland)

^ad UNIVERSITY OF ICELAND   (Iceland)

^ae UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^af UNIVERSITY OF WASHINGTON   (United States)

^ag PFIZER INC   (United States)

^ah BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ai FRAMINGHAM HEART STUDY   (United States)

^aj Department of Obstetrics Gynecology   (United States)

^ak WEILL CORNELL MEDICAL COLLEGE   (United States)

^al BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^am UNIVERSITY OF LEICESTER   (United Kingdom)

^an GLENFIELD HOSPITAL   (United Kingdom)

^ao ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^ap NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^aq UNIVERSITY OF NOTTINGHAM   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER MODEL; CONTROLLED STUDY; EXPRESSION QUANTITATIVE TRAIT LOCI; FEMALE; FETUS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE LOCUS; GENE ONTOLOGY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; LUNG DEVELOPMENT; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PLEIOTROPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADVERSE EFFECTS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; SMOKING;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84943376336     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00380-X     Document Type: Article

References (73)

1. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000, 118:656-664.
2. Lewiiter FI, Tager IB, McGue M, et al. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984, 120:518-530.
3. Wilk JB, Djousse L, Arnett DK, et al. Evidence for major genes influencing pulmonary function in the NHLBI Family Heart Study. Genet Epidemiol 2000, 19:81-94.
4. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010, 42:36-44.
5. Soler Artigas M, Loth DW, Wain LV, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011, 43:1082-1090.
6. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010, 42:45-52.
7. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
8. Nicolae DL, Gamazon E, Zhang W, et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010, 6:e1000888.
9. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
10. Schadt EE, Molony C, Chudin E, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008, 6:e107.
11. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250.
12. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428.
13. Hao K, Bossé Y, Nickle DC, et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet 2012, 8:e1003029.
14. Lamontagne M, Couture C, Postma DS, et al. Refining susceptibility loci of chronic obstructive pulmonary disease with lung eQTLs. PLoS ONE 2013, 8:e70220.
15. Obeidat Me, Miller S, Probert K, et al. GSTCD and INTS12 regulation and expression in the human lung. PLoS ONE 2013, 8:e74630.
16. Dijkstra AE, Smolonska J, van den Berge M, et al. Susceptibility to chronic mucus hypersecretion, a genome wide association study. PLoS ONE 2014, 9:e91621.
17. Thun GA, Imboden M, Ferrarotti I, et al. Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. PLoS Genet 2013, 9:e1003585.
18. Nadeau JH, Dudley AM Systems genetics. Science 2011, 331:1015-1016.
19. Civelek M, Lusis AJ Systems genetics approaches to understand complex traits. Nat Rev Genet 2014, 15:34-48.
20. Li H Systems genetics in "-omics" era: current and future development. Theory Biosci 2013, 132:1-16.
21. Powell JE, Henders AK, McRae AF, et al. The Brisbane Systems Genetics Study: genetical genomics meets complex trait genetics. PLoS ONE 2012, 7:e35430.
22. Taneera J, Lang S, Sharma A, et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metabolism 2012, 16:122-134.
23. Wang J, Duncan D, Shi Z, et al. WEB-based gene set analysis toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013, 41:W77-W83.
24. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
25. Hindorff LA MacArthur J, Morales J, et al. A catalog of published genome-wide association studies (accessed April 25, 2014). http://www.genome.gov/gwastudies.
26. Auerbach RK, Chen B, Butte AJ Relating genes to function: identifying enriched transcription factors using the ENCODE ChIP-Seq significance tool. Bioinformatics 2013, 29:1922-1924.
27. Ward LD, Kellis M HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012, 40:D930-D934.
28. Westra H-J, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013, 45:1238-1243.
29. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012, 44:981-990.
30. Zhou X, Baron RM, Hardin M, et al. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP. Hum Mol Genet 2012, 21:1325-1335.
31. Castaldi PJ, Cho MH, Zhou X, et al. Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. Hum Mol Genet 2015, 24:1200-1210.
32. Krzywinski MI, Schein JE, Birol I, et al. Circos: an information aesthetic for comparative genomics. Genome Research 2009, 19:1639-1645.
33. Liu C Brain expression quantitative trait locus mapping informs genetic studies of psychiatric diseases. Neurosci Bull 2011, 27:123-133.
34. Warburton D, Gauldie J, Bellusci S, et al. Lung development and susceptibility to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:668-672.
35. Checkley W, West KP, Wise RA, et al. Maternal vitamin A supplementation and lung function in offspring. N Engl J Med 2010, 362:1784-1794.
36. Massaro D, Massaro DG Lung development, lung function, and retinoids. N Engl J Med 2010, 362:1829-1831.
37. Shi W, Warburton D Is COPD in adulthood really so far removed from early development?. Eur Respir J 2010, 35:12-13.
38. Ranganathan S Lung development, lung growth and the future of respiratory medicine. Eur Respir J 2010, 36:716-717.
39. Shi W, Chen F, Cardoso WV Mechanisms of lung development. Proc Am Thorac Soc 2009, 6:558-563.
40. Kerkhof M, Boezen HM, Granell R, et al. Transient early wheeze and lung function in early childhood associated with chronic obstructive pulmonary disease genes. J Allergy Clin Immunol 33: 68-76.e4.
41. Chuang P-T, Kawcak TN, McMahon AP Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev 2003, 17:342-347.
42. Pepicelli CV, Lewis PM, McMahon AP Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol 1998, 8:1083-1086.
43. Alejandre-Alcázar MA, Michiels-Corsten M, Vicencio AG, et al. TGF-β signaling is dynamically regulated during the alveolarization of rodent and human lungs. Dev Dyn 2008, 237:259-269.
44. Bartram U, Speer CP The role of transforming growth factor beta in lung development and disease. Chest 2004, 125:754-765.
45. Morimoto M, Liu Z, Cheng H-T, et al. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci 2010, 123:213-224.
46. Collins BJ, Kleeberger W, Ball DW Notch in lung development and lung cancer. Semin Cancer Biol 2004, 14:357-364.
47. Chytil F Vitamin A and lung development. Pediatr Pulmonol 1985, 1(suppl):S115-S117.
48. Biesalski HK, Nohr D Importance of vitamin-A for lung function and development. Mol Aspects Med 2003, 24:431-440.
49. Malpel S, Mendelsohn C, Cardoso WV Regulation of retinoic acid signaling during lung morphogenesis. Development 2000, 127:3057-3067.
50. Hogg JC, Pierce RA Remodelling of peripheral lung tissue in COPD. Eur Respir J 2008, 31:913-914.
51. Campbell J, McDonough J, Zeskind J, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med 2012, 4:67.
52. Sirota M, Dudley JT, Kim J, et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011, 3:96ra77.
53. Jahchan NS, Dudley JT, Mazur PK, et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov 2013, 3:1364-1377.
54. Barnes PJ Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009, 71:451-464.
55. Mizuno S, Yasuo M, Bogaard HJ, et al. Inhibition of histone deacetylase causes emphysema. Am J Physiol Lung Cell Mol Physiol 2011, 300:L402-L413.
56. Krishnapati LS, Ghaskadbi S Identification and characterization of VEGF and FGF from Hydra. Int J Dev Biol 2013, 57:897-906.
57. Spitzmaul G, Gumilar F, Dilger JP, et al. The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms. Br J Pharmacol 2009, 157:804-817.
58. Gentry CL, Lukas RJ Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther 2001, 299:1038-1048.
59. Zhou H, Yang J, Li D, et al. Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population. J Hum Genet 2012, 57:738-746.
60. Hardin M, Zielinski J, Wan ES, et al. CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland. Am J Respir Cell Mol Biol 2012, 47:203-208.
61. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5:e1000421.
62. Cho MH, McDonald M-LN, Zhou X, et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2014, 2:214-225.
63. Schuller HM Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?. Nature Rev Cancer 2009, 9:195-205.
64. Paleari L, Negri E, Catassi A, et al. Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Am J Respir Crit Care Med 2009, 179:1141-1150.
65. Gwilt CR, Donnelly LE, Rogers DF The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?. Pharmacol Ther 2007, 115:208-222.
66. Kosten TR, Wu G, Huang W, et al. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase. Biol Psychiatry 2013, 73:219-224.
67. Ozdemir E, Bagcivan I, Gursoy S Role of D(1)/D(2) dopamin receptors antagonist perphenazine in morphine analgesia and tolerance in rats. Bosn J Basic Med Sci 2013, 13:119-125.
68. Hals PA, Hall H, Dahl SG Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding. Eur J Pharmacol 1986, 125:373-381.
69. Tashkin DP, Rabinoff M, Noble EP, et al. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the Lung Health Study. COPD 2012, 9:620-628.
70. Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 2014, 10:e1004383.
71. Li L, Kabesch M, Bouzigon E, et al. Using eQTL weights to improve power for genome-wide association studies: a genetic study of childhood asthma. Front Genet 2013, 4:103.
72. He X, Fuller CK, Song Y, et al. Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am J Hum Genet 2013, 92:667-680.
73. Flutre T, Wen X, Pritchard J, et al. A statistical framework for joint eQTL analysis in multiple tissues. PLoS Genet 2013, 9:e1003486.